WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia

WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia

October 2011

Pre-eclampsia stands out among the hypertensive disorders for its impact on maternal and neonatal health. It is one of the leading causes of maternal and perinatal mortality and morbidity worldwide.

The primary goal of the present guidelines is to improve the quality of care and outcomes for pregnant women presenting with pre-eclampsia and its main complications (e.g. eclampsia). The target audience of these guidelines includes obstetricians, midwives, general medical practitioners, health-care managers and public health policy-makers, particularly those in under-resourced settings. The guidance provided is evidence-informed and covers selected topics related to the management of pre-eclampsia and eclampsia that were regarded as critical questions by an international, multidisciplinary group of health-care workers, consumers and other stakeholders. These guidelines are not intended as a comprehensive guide on the management of pre-eclampsia and eclampsia.

 

Recommendations

 

WHO recommendation on calcium supplementation during pregnancy
Updated: November 2016

WHO recommendation on low-dose acetylsalicylic acid (aspirin) for pre-eclampsia prevention in high-risk women 
Published: October 2011 

WHO recommendation on timing of low-dose acetylsalicylic acid (aspirin) for pre-eclampsia prevention in high-risk women
Published: October 2011 

WHO recommendation on antihypertensive drugs for women with severe hypertension during pregnancy
Published: October 2011 

WHO recommendation on choice and route of administration of antihypertensive drugs for women with severe hypertension during pregnancy
Published: October 2011 

WHO recommendation on magnesium sulfate for the prevention of eclampsia in women with severe pre-eclampsia
Published: October 2011 

WHO recommendation on magnesium sulfate as the first line anticonvulsant  in women with eclampsia
Published: October 2011 

WHO recommendation on magnesium sulfate regimen to prevent and treat eclampsia
Published: October 2011

WHO recommendation on use of magnesium sulfate to prevent and treat eclampsia, where the full regimen cannot be administered 
Published: October 2011

WHO recommendation on induction for the prevention of eclampsia in women with severe pre-eclampsia when the fetus is not viable
Published: October 2011

WHO recommendation on induction for the prevention of eclampsia in women with severe pre-eclampsia, a viable fetus and before 34 weeks of gestation
Published: October 2011

WHO recommendation on induction for the prevention of eclampsia in women with severe pre-eclampsia, a viable fetus and between 34 and 36 (plus 6 days) weeks of gestation
Published: October 2011

WHO recommendation on induction for women with severe pre-eclampsia at term
Published: October 2011

WHO recommendation on induction for women with mild pre-eclampsia or mild gestational hypertension at term
Published: October 2011

WHO recommendation on postpartum treatment of women treated with antihypertensive drugs antenatally
Published: October 2011

WHO recommendation on treatment for women with severe postpartum hypertension
Published: October 2011

WHO recommendation regarding advice to rest at home as primary prevention of pre-eclampsia and hypertensive disorders of pregnancy
Published: October 2011

WHO recommendation against salt restriction for the prevention of pre-eclampsia
Published: October 2011

WHO recommendation regarding Vitamin D supplementation during pregnancy
Published: December 2016

WHO recommendation against vitamin C or vitamin E supplementation during pregnancy for the prevention of pre-eclampsia
Published: December 2016

WHO recommendation against the use of diuretics for the prevention of pre-eclampsia during pregnancy
Published: October 2011

WHO recommendation on the use of corticosteroids for treating HELLP syndrome
Published: October 2011